Discontinuation report REFRESH REDNESS RELIEF
| Report ID | 173240 |
| Drug Identification Number | 02315920 |
| Brand name | REFRESH REDNESS RELIEF |
| Common or Proper name | naphazoline ophthalmic sol 0.1% |
| Company Name | ALLERGAN INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | NAPHAZOLINE HYDROCHLORIDE |
| Strength(s) | 0.1% |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC OPHTHALMIC |
| Packaging size | 15ml |
| ATC code | S01GA |
| ATC description | DECONGESTANTS AND ANTIALLERGICS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2022-11-01 |
| Remaining supply date | |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: [email protected] Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2022-11-02 | English | Compare |
| v2 | 2022-11-01 | French | Compare |
| v1 | 2022-11-01 | English | Compare |
Showing 1 to 3 of 3